Company Email Format

Elastrin Therapeutics

Biotechnology Research House, United States 8 employees

Employees: 8
Contacts: 2
Emails: 2

elastrin.com LinkedIn Crunchbase

Elastrin Therapeutics Overview

Headquarters: House, United States
Website: elastrin.com
Industry: Biotechnology Research
Employees: 8
Founded: 2017
Funding: 4.8M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Biotech cardiovascular diseases drug discovery elastrin

About Elastrin Therapeutics

Elastrin Therapeutics is a UK and US-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice. Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries.

Elastrin Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Elastrin Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Douglas Mulhall	Healthy Product Developer +impakt, Epea	Canada	Email
Yuri Martina M.d., Ph.d., M.b.a., PMP	Chief Development and Medical Officer	London, England, United Kingdom	Email
Harsh Shah	Machine Learning Engineer - Data	Seattle, Washington, United States	View
Mirko Stange	Founder of Dxpx - the Investor		View